Canadians Say Impaired Driving Is a Serious Public Safety Issue and Want Governments to Act GlobeNewswire January 28, 2026 OAKVILLE, Ontario, Jan. 28, 2026 (GLOBE NEWSWIRE) — An overwhelming majority of Canadians say impaired driving is a serious public safety issue and support MADD Canada's policies for change, according to a new national survey, conducted […]

Gearing Up for The Big Game: WeShop Announces Electronics Offerings with Best Buy, Samsung, Lenovo and eBay GlobeNewswire January 28, 2026 NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) — WeShop Holdings Limited (“WeShop” or the “Company”) (NASDAQ: WSHP), the world's first community-owned social commerce platform, today announced retail partnerships with Best Buy, Samsung, Lenovo and

DoubleDown Interactive to Report 2025 Fourth Quarter Results on February 11 and Host Conference Call and Webcast GlobeNewswire January 28, 2026 SEOUL, South Korea, Jan. 28, 2026 (GLOBE NEWSWIRE) — DoubleDown Interactive Co., Ltd. (NASDAQ: DDI) (“DoubleDown” or the “Company“), a leading developer and publisher of digital games on mobile and web-based platforms, announced today

NFI schedules fourth quarter 2025 financial results and conference call GlobeNewswire January 28, 2026 WINNIPEG, Manitoba, Jan. 28, 2026 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (NFI or the Company) a leader in bus and coach mobility solutions, today announced it intends to release its fourth quarter 2025 financial results

Seamless Therapeutics Announces Global Research Collaboration with Lilly to Develop Programmable Recombinase-based Therapeutics for Hearing Loss GlobeNewswire January 28, 2026 — Collaboration will advance a next generation gene editing approach by combining Seamless' expertise in developing highly precise and efficient recombinases with Lilly's extensive development expertise in genetic hearing disorders — — Companies will leverage

Indivior to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Webcast on February 26áµ—Ê° GlobeNewswire January 28, 2026 RICHMOND, Va., Jan. 28, 2026 (GLOBE NEWSWIRE) — Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will report its fourth quarter and full-year 2025 financial results on Thursday, February 26, 2026, at 7:00 a.m.

Teva Innovative Portfolio and Consistent Execution of Pivot to Growth Strategy Deliver Third Consecutive Year of Growth; Pipeline Positioned to Unlock Significant Value Potential GlobeNewswire January 28, 2026 Teva delivers 3 consecutive years of growth – 2025 revenues of $17.3 billion, an increase of 4% year-over-year (YoY) in U.S. dollars, or 3% in local currency

Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates GlobeNewswire January 28, 2026 Interim results from Phase 2b clinical trial of RAD 101 showed 92% of evaluable participants met the primary endpoint of MRI concordance in imaging study of patients with brain metastases Interim data from additional Cohorts of the Phase 1 clinical trial of

OMass Therapeutics Appoints Jonathan Montagu as Chair of the Board of Directors GlobeNewswire January 28, 2026 OXFORD, United Kingdom, Jan. 28, 2026 (GLOBE NEWSWIRE) — OMass Therapeutics ('OMass' or 'the Company'), a biotechnology company identifying medicines against highly validated target ecosystems such as membrane proteins or intracellular complexes, today announced updates to its Board of

Loblaw Companies Limited Announces the Timing of the 2025 Fourth Quarter and Fiscal Year Earnings Release GlobeNewswire January 28, 2026 BRAMPTON, Ontario, Jan. 28, 2026 (GLOBE NEWSWIRE) — Loblaw Companies Limited (TSX: L) announced today that it will release its 2025 fourth quarter and full year results on February 25, 2026, at approximately 6:30 a.m.